BioCryst Pharmaceuticals, Inc. today announced new real-world evidence showing that patients with hereditary angioedema (HAE) who have normal C1-inhibitor (HAE-nC1-INH) level and function had a reduction in monthly attack rates after starting oral, once-daily berotralstat.
Researchers develop terahertz imaging systems for cancer detection
Medical imaging via X-rays, CT scans, MRIs and ultrasounds provide health-care professionals with unique perspectives and a better understanding of what’s happening inside a patient’s